Literature DB >> 12161493

A prospective controlled study of the impact of hyperthyroidism on reproductive function in males.

G E Krassas1, N Pontikides, V Deligianni, K Miras.   

Abstract

The aim of this prospective controlled study was to ascertain the effect of hyperthyroidism on sperm quality and composition. We studied 23 thyrotoxic male patients, aged 43.8 +/- 2.4 yr (mean +/- SEM), and 15 healthy male controls of approximately the same age (42.2 +/- 2.2 yr). Two semen analyses at intervals of 2-3 wk were obtained before and about 5 months after euthyroidism was achieved either by methimazole alone (14 patients) or (131)I plus methimazole (9 patients). Total fructose, zinc (Zn), and magnesium (Mg) were also measured in seminal plasma in 16 patients, because 7 had semen volume less than 2 ml. In the control group semen analysis was performed only once. Mean (+/-SEM) semen volume was within normal range both in patients (3.3 +/- 0.2 ml) and controls (3.5 +/- 0.4 ml; P = NS). Mean sperm density was lower in patients, although the difference compared with controls did not reach statistical significance (35.7 +/- 5.3 vs. 51.5 +/- 6.1 x 10(6)/ml; P = 0.062). The same was found with sperm morphology (68 +/- 7% vs. 78 +/- 8%; P = NS). Finally, mean motility was lower in thyrotoxic males than in controls (28 +/- 8% vs. 57 +/- 7%; P < 0.01). After treatment, sperm density and motility improved [35.7 +/- 5.3 vs. 43.3 +/- 6.5 x 10(6)/ml (P = NS) and 28 +/- 8% vs. 45 +/- 7% (P < 0.05), respectively], but sperm morphology did not change (68 +/- 7% vs. 70 +/- 6%; P = NS). Mean values for fructose, Zn, and Mg did not differ between controls and patients either before or after achievement of euthyroidism [9.2 +/- 0.7, 3.0 +/- 0.5, and 4.2 +/- 0.7 nmol/liter vs. 8.6 +/- 0.9, 3.0 +/- 0.5, and 4.7 +/- 0.8 nmol/liter (patients before) and 9.1 +/- 0.7, 3.1 +/- 0.6, and 4.5 +/- 0.9 nmol/liter (patients after treatment) for fructose, Zn, and Mg, respectively]. Moreover, according to the treatment given, no statistically significant differences were found before or after treatment. Finally, seminal plasma fructose, Zn, and Mg levels did not correlate with sperm parameters or with pretreatment thyroid hormone levels. In conclusion, the results of our study indicate that male patients with hyperthyroidism have abnormalities in seminal parameters, mainly sperm motility. These abnormalities improve or normalize when the patients become euthyroid. Restoration of sperm parameters was independent of the treatment provided for the hyperthyroid syndrome. Moreover, seminal plasma elements, such as fructose, Zn, and Mg, did not correlate with sperm density, motility, or morphology.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12161493     DOI: 10.1210/jcem.87.8.8714

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  11 in total

Review 1.  Impact of thyroid disease on testicular function.

Authors:  Sandro La Vignera; Roberto Vita; Rosita A Condorelli; Laura M Mongioì; Silvia Presti; Salvatore Benvenga; Aldo E Calogero
Journal:  Endocrine       Date:  2017-04-20       Impact factor: 3.633

2.  2021 European Thyroid Association Guideline on Thyroid Disorders prior to and during Assisted Reproduction.

Authors:  Kris Poppe; Peter Bisschop; Laura Fugazzola; Gesthimani Minziori; David Unuane; Andrea Weghofer
Journal:  Eur Thyroid J       Date:  2021-01-21

3.  Association between seminal plasma copper and magnesium levels with oxidative stress in iraqi infertile men.

Authors:  Omar F Abdul-Rasheed
Journal:  Oman Med J       Date:  2010-07

Review 4.  The Impact of Oxidative Stress on Testicular Function and the Role of Antioxidants in Improving it: A Review.

Authors:  Nematollah Asadi; Mahmoud Bahmani; Arash Kheradmand; Mahmoud Rafieian-Kopaei
Journal:  J Clin Diagn Res       Date:  2017-05-01

Review 5.  Thyroid disease and male reproductive function.

Authors:  G E Krassas; P Perros
Journal:  J Endocrinol Invest       Date:  2003-04       Impact factor: 4.256

Review 6.  Testosterone replacement therapy: role of pituitary and thyroid in diagnosis and treatment.

Authors:  Megan Crawford; Laurence Kennedy
Journal:  Transl Androl Urol       Date:  2016-12

Review 7.  Frontiers in hormone therapy for male infertility.

Authors:  Iyad Khourdaji; Haerin Lee; Ryan P Smith
Journal:  Transl Androl Urol       Date:  2018-07

Review 8.  Antioxidant systems and oxidative stress in the testes.

Authors:  R John Aitken; Shaun D Roman
Journal:  Oxid Med Cell Longev       Date:  2008 Oct-Dec       Impact factor: 6.543

Review 9.  Thyroid and male reproduction.

Authors:  Anand Kumar; Skand Shekhar; Bodhana Dhole
Journal:  Indian J Endocrinol Metab       Date:  2014-01

Review 10.  Endocrinopathies and Male Infertility.

Authors:  Pallav Sengupta; Sulagna Dutta; Ivan Rolland Karkada; Suresh V Chinni
Journal:  Life (Basel)       Date:  2021-12-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.